These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
178 related articles for article (PubMed ID: 18834365)
1. Use of ACE inhibitors and ARBs in hypertensive women of childbearing age. Martin U; Foreman MA; Travis JC; Casson D; Coleman JJ J Clin Pharm Ther; 2008 Oct; 33(5):507-11. PubMed ID: 18834365 [TBL] [Abstract][Full Text] [Related]
2. Physician conformity and patient adherence to ACE inhibitors and ARBs in patients with diabetes, with and without renal disease and hypertension, in a medicaid managed care organization. Cooke CE; Fatodu H J Manag Care Pharm; 2006 Oct; 12(8):649-55. PubMed ID: 17269843 [TBL] [Abstract][Full Text] [Related]
4. Antihypertensive prescribing patterns and hypertension control in females of childbearing age. White BM; Anderson SL; Marrs JC Am J Health Syst Pharm; 2021 Jul; 78(14):1317-1322. PubMed ID: 33848330 [TBL] [Abstract][Full Text] [Related]
5. Risk of Osteoporotic Fractures With Angiotensin II Receptor Blockers Versus Angiotensin-Converting Enzyme Inhibitors in Hypertensive Community-Dwelling Elderly. Butt DA; Mamdani M; Gomes T; Lix L; Lu H; Tu K; J Bone Miner Res; 2014 Nov; 29(11):2483-8. PubMed ID: 24806397 [TBL] [Abstract][Full Text] [Related]
6. Outpatient use of cardiovascular drugs during pregnancy. Andrade SE; Raebel MA; Brown J; Lane K; Livingston J; Boudreau D; Rolnick SJ; Roblin D; Smith DH; Dal Pan GJ; Scott PE; Platt R Pharmacoepidemiol Drug Saf; 2008 Mar; 17(3):240-7. PubMed ID: 18200619 [TBL] [Abstract][Full Text] [Related]
7. Underuse of ACE inhibitors and angiotensin II receptor blockers in elderly patients with diabetes. Winkelmayer WC; Fischer MA; Schneeweiss S; Wang PS; Levin R; Avorn J Am J Kidney Dis; 2005 Dec; 46(6):1080-7. PubMed ID: 16310574 [TBL] [Abstract][Full Text] [Related]
8. Angiotensin II type 1 receptor blockade: high hopes sent back to reality? Grothusen A; Divchev D; Luchtefeld M; Schieffer B Minerva Cardioangiol; 2009 Dec; 57(6):773-85. PubMed ID: 19942847 [TBL] [Abstract][Full Text] [Related]
9. Pregnancy protection and pregnancies in women prescribed ACE inhibitors or ARBs: a cross-sectional study in primary care. Lovegrove E; Robson J; McGettigan P Br J Gen Pract; 2020 Nov; 70(700):e778-e784. PubMed ID: 33020169 [TBL] [Abstract][Full Text] [Related]
10. Does comorbidity explain trends in prescribing of newer antihypertensive agents? Greving JP; Denig P; van der Veen WJ; Beltman FW; Sturkenboom MC; de Zeeuw D; Haaijer-Ruskamp FM J Hypertens; 2004 Nov; 22(11):2209-15. PubMed ID: 15480107 [TBL] [Abstract][Full Text] [Related]
11. Are angiotensin-converting enzyme inhibitors and angiotensin receptor blockers safe in pregnancy: a report of ninety-one pregnancies. Karthikeyan VJ; Ferner RE; Baghdadi S; Lane DA; Lip GY; Beevers DG J Hypertens; 2011 Feb; 29(2):396-9. PubMed ID: 21119533 [TBL] [Abstract][Full Text] [Related]
12. Effects of renin-angiotensin system inhibition on end-organ protection: can we do better? Weir MR Clin Ther; 2007 Sep; 29(9):1803-24. PubMed ID: 18035185 [TBL] [Abstract][Full Text] [Related]
13. Influence of pharmacist intervention on prescribing of angiotensin-converting-enzyme inhibitors, angiotensin II-receptor blockers, and aspirin for diabetic patients. LaMarr B; Valdez C; Driscoll K; Ryan M Am J Health Syst Pharm; 2010 Feb; 67(4):290-4. PubMed ID: 20133534 [TBL] [Abstract][Full Text] [Related]
14. Discharge use of angiotensin receptor blockers provides comparable effects with angiotensin-converting enzyme inhibitors on outcomes in patients hospitalized for heart failure. Tsuchihashi-Makaya M; Furumoto T; Kinugawa S; Hamaguchi S; Goto K; Goto D; Yamada S; Yokoshiki H; Takeshita A; Tsutsui H; Hypertens Res; 2010 Mar; 33(3):197-202. PubMed ID: 19960016 [TBL] [Abstract][Full Text] [Related]
15. Compliance, persistence, and switching patterns for ACE inhibitors and ARBs. Vegter S; Nguyen NH; Visser ST; de Jong-van den Berg LT; Postma MJ; Boersma C Am J Manag Care; 2011 Sep; 17(9):609-16. PubMed ID: 21902446 [TBL] [Abstract][Full Text] [Related]
16. Investigation of angioedema associated with the use of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers. Malde B; Regalado J; Greenberger PA Ann Allergy Asthma Immunol; 2007 Jan; 98(1):57-63. PubMed ID: 17225721 [TBL] [Abstract][Full Text] [Related]
17. Angiotensin-converting enzyme inhibitors or angiotensin II receptor blockers and the risk of developing rheumatoid arthritis in antihypertensive drug users. de Jong HJ; Vandebriel RJ; Saldi SR; van Dijk L; van Loveren H; Cohen Tervaert JW; Klungel OH Pharmacoepidemiol Drug Saf; 2012 Aug; 21(8):835-43. PubMed ID: 22674737 [TBL] [Abstract][Full Text] [Related]
18. [Assessment of the utilization of angiotensin receptor blockers in hypertension]. Peña Cabia S; Ricote Lobera I; Santos Mena B; Hidalgo Correas FJ; Climent Florez B; García Díaz B Farm Hosp; 2013; 37(5):394-8. PubMed ID: 24128102 [TBL] [Abstract][Full Text] [Related]
19. Uptake of angiotensin II receptor blockers in the treatment of hypertension. Greving JP; Denig P; van der Veen WJ; Beltman FW; Sturkenboom MC; de Zeeuw D; Haaijer-Ruskamp FM Eur J Clin Pharmacol; 2005 Jul; 61(5-6):461-6. PubMed ID: 15912393 [TBL] [Abstract][Full Text] [Related]
20. Hypertension management in outpatient visits by diabetic patients. Aparasu RR; Aparasu A Res Social Adm Pharm; 2008 Sep; 4(3):284-91. PubMed ID: 18794038 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]